Continued">Continued">Continued">Pediatric Oncology Fellowship – Children Cancer Hospital Egypt 57357
558981

Pediatric Oncology

  • 19057
  • (202) 25351500

Pediatric Oncology Fellowship

Program ID

  • Program Name: Pediatric Oncology Fellowship
  • Program Description: The program curriculum uses the American Academy of Pediatrics Oncology curriculum as a guide. Training is centered primarily on CCHE and formal collaboration with DF/BC.
  • Collaboration: Dana-Farber Boston Children’s Cancer and Blood Disorders Center.
  • Degree /Certificate: Training Certificate from the CCHF 57357 and DF/BC.
  • Duration: The program lasts 36 months, including vacation time (3 weeks per year in the first two years).
  • Location: Based at 57357, Egypt, with a rotation to DFBC in Boston, MA, USA. Other affiliated hospitals or institutions in the USA may also participate in the program.
  • Mode of Delivery: On-site live training.
  • Program Content Model: Course content is set using the American Academy of Pediatric Oncology curriculum guidelines.

2020-2021 Review

    • Number of Applicants: 12 Applicants.

 

    • Shortlist: 9 Applicants.

 

    • Selection Process Outcome “No. of participants”: 4 Fellows.

 

    • No. of External Candidates: 0

 

  • Participants Scientific Activities:
    • Weekly Lectures.
    • Study team meetings CCHE.
    • Combined clinics CCHE (50%).
    • Mortality and morbidity rounds CCHE.
    • Visiting lecturers.
    • Monthly video conferencing of difficult cases at both institutions.
    • DFBC tumor board and other appropriate joint tutorial sessions.
    • Assignments.
  • International Visits

  • Visitors: 2021 visits From the Boston team. (3 visits)

      • 1st Visit: April 2021, “Dr. Leslie Liehman, Dr. Liliana Gomrinova & Dr. Mark Keirn.”
        • Visit Duration: 4 days (4th & 7th January 2020)
        • Visit Goal:
          • Clinical rounds.
          • Research project follow-up.
          • Committee meeting.
          • PNOC Meeting.
          • Case presentations.
        • Visit Outcome: revising research projects and training the fellows on how to make a clinical presentation on any case. The fellows presented cases and discussed the treatment plan with the committee.

      • 2nd Visit: July 2021 “Dr. Leslie Lehman, Dr. Liliana Gomrinova & Dr. Mark Keirn”
        • Visit Duration: 4 days (4th to 7th July 2021)
        • Visit Goals:
          • Fellow’s assessment and evaluation.
          • Written final exam for fellows 2018.
          • OSCE exam for fellows 2018.
          • Interviewing new applicants.
          • Finalize the selection process results and select the new patch for 2021.
          • Project discussions.
        • Visit Outcome:
          • Patch 2021 selection.
          • Final exam for fellows 2018.
          • Projects tracking.
          • Followup fellows activities.

    3rd Visit: “Dr. Mark Kiern, DR Lei sly Lehman, and Dr. Liliana Joumnerova.”

      • Visit Duration: 4 days (31st of October, 2021 to 3rd of November, 2021)
      • Visit Goals:
        • Committee meetings are held to revise all the fellows’ activities.
        • Revising all the fellows' projects from 2015 to 2020.
      • Visit Outcome:
        • Following the fellows’ activities.
        • Revising all the projects' progress for 6 Patches.
  • Participant Projects Sheet: *in Appendix 1
  •  
  • Publication Project: *in Appendix 1
  •  
  • Pass Rate (No. of successful candidates/Total no of candidates): 100%

Publication Project

Pediatric Oncology Fellowship Research Projects

Published Projects

Fellow NameClassProject titleJournal NamePublication
link
Impact Factor
Hisham Moneib2014Day +100 Platelet Count Predicts Survival After Allogeneic
Hematopoietic
Stem-Cell Transplantation in
Children with Hematologic Malignancies.
(Clinical Lymphoma, Myeloma and leukemia) 2019https://www.clinical-lymphoma-myeloma-
leukemia.com/article/
S21 52-2650(18)30585-8/fulltext
2.29
Noura Mahmoud2014Outcome of Childhood Acute
Megakaryoblastic Leukemia:
Children’s Cancer Hospital Egypt 57357 Experience.
(Clinical Lymphoma, Myeloma and leukemia) 2018https://www.clinical-lymphoma-myeloma-
leukemia.com/article/
S21 52-2650(18)30585-8/fulltext
Ahmed Emad2015Outcome of
Children Treated
for Infantile
Hepatic Hemangioendothelioma.
(Pediatric Hematology Oncology. 2019)https://journals.lww.com/jpho-online/
Abstract/2020/03000/
Outcome_of_Children_Treated_
for_Infantile_Hepatic.7.aspx
0.947
Ahmed Mahdy2015Incidence, risk factors, and outcome
of blood stream infections
during the first 100 days post‐pediatric allogeneic
and autologous hematopoietic
stem cell transplantations
(Pediatric transplantation, 2019)https://onlinelibrary.wiley.com/
doi/full/10.1111/petr.13610
1.25
Mariam Elsherif2015MECOM gene overexpression in pediatric patients with acute myeloid leukemiaACTA ONCOLOGICAhttps://doi.org/10.1080/0284186X.2022.20256114.2
ProgramsStart dateEnd dateNo. of
attendees
Affiliation
Year 2014
Pediatric Oncology Fellowship cohort 11-Nov-14Jul-174Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2015
Pediatric Oncology Fellowship cohort 21-Dec-15Jul-186Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2016
Pediatric Oncology Fellowship cohort 31-Dec-16Jul-196Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2017
Pediatric Oncology Fellowship cohort 41-Dec-17Jul-206Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2018
Pediatric Oncology Fellowship cohort 51-Dec-18Jul-216Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2019
Pediatric Oncology Fellowship cohort 61-Dec-19Ongoing4Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2020
Pediatric Oncology Fellowship cohort 71-Dec-20Ongoing4Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)
Year 2021
Pediatric Oncology Fellowship cohort 81-Dec-21Ongoing4Dana Farber Boston Children's Cancer and Blood Disorders Center (DFBC)

Pass Rate (No. of successful candidates / Total no of candidates): 100%